Concepedia

George Poulogiannis

GP

34

Publications

5.3K

Citations

27

H-Index

2007

Active since

Affiliations

University of Cambridge(Current)

Beth Israel Deaconess Medical Center

Harvard University

Institute of Cancer Research

Imperial College London

George Poulogiannis is an author at University of Cambridge specializing in medicine, cell biology, and cancer research.

Top concepts

MedicineCell BiologyCancer ResearchTumor BiologyCancer BiologyCell SignalingTumor MicroenvironmentPathologyColorectal CancerSignal Transduction

Publications per year

2007–2024

34

Publications

34

Inhibition of Pyruvate Kinase M2 by Reactive Oxygen Species Contributes to Cellular Antioxidant Responses

Dimitrios Anastasiou, George Poulogiannis, John M. Asara et al. · Science · 2011 · 1.2K citations · Full text

Lipid Peroxidation, Cell Death, Metabolic Remodeling +19

Phosphoproteomic Analysis Identifies Grb10 as an mTORC1 Substrate That Negatively Regulates Insulin Signaling

Yonghao Yu, Sang-Oh Yoon, George Poulogiannis et al. · Science · 2011 · 868 citations

Insulin Signaling, Signaling Pathway, Receptor Tyrosine Kinase +19

The mTORC1 Pathway Stimulates Glutamine Metabolism and Cell Proliferation by Repressing SIRT4

Alfred Csibi, Sarah‐Maria Fendt, Chenggang Li et al. · Cell · 2013 · 583 citations · Full text

Signal Transduction, Cell Regulation, Molecular Pathway +7

Asparagine bioavailability governs metastasis in a model of breast cancer

Simon Knott, Elvin Wagenblast, Showkhin Khan et al. · Nature · 2018 · 530 citations · Full text

Breast Oncology, Oncology, Medicine +8

<i>PARK2</i> deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in <i>Apc</i> mutant mice

George Poulogiannis, Rebecca E. McIntyre, Maria Dimitriadi et al. · Proceedings of the National Academy of Sciences · 2010 · 230 citations · Full text

Rows per page

1–5 of 34